MARKET

TARO

TARO

Taro Pharm
NYSE

Real-time Quotes | Nasdaq Last Sale

73.60
-1.87
-2.48%
Closed 16:00 05/10 EDT
OPEN
74.88
PREV CLOSE
75.47
HIGH
75.11
LOW
73.60
VOLUME
9.07K
TURNOVER
--
52 WEEK HIGH
80.00
52 WEEK LOW
53.95
MARKET CAP
2.82B
P/E (TTM)
-9.3033
1D
5D
1M
3M
1Y
5Y
Econazole Nitrate Cream Market Growth, Share, 2021 Global Industry Trends, Size, Revenue, CAGR Status, Business Opportunities and Demand Forecast to 2027
May 07, 2021 (The Expresswire) -- Global "Econazole Nitrate Cream Market" (2021) analyzes the impact of various Factors influencing the market improvement...
The Express Wire · 3d ago
Topical Hydrocortisone Market 2021-2028 Size, Market Share, Application Analysis, Growth Trends, and Key Players By Ameco Research
pune, India, Fri, 07 May 2021 02:33:18 / Comserve Inc. / -- The global Topical Hydrocortisone market is segmented by company, region (country), by Type, and...
Comserve · 3d ago
Global Pseudotumor Cerebri Market CAGR Status 2021 Industry Size, Share, Growth Factor, Market Overview with Covid-19 Impact till 2025
May 05, 2021 (The Expresswire) -- Global “Pseudotumor Cerebri Market” research report provides detailed analysis of market size growth rate by end user,...
The Express Wire · 5d ago
Econazole Nitrate Cream Market 2021-2027: In-Depth Industry Analysis on Size, Cost Structure, Prominent Key Players (Mylan, Perrigo Israel, Taro Pharmaceutical Industries Ltd., Teligent Pharma Inc, etc)
May 05, 2021 (The Expresswire) -- "Final Report will add the analysis of the impact of COVID-19 on this industry." The global “Econazole Nitrate Cream...
The Express Wire · 5d ago
Onychomycosis Market Size, Share, Trends, Analysis and Forecast 2027
May 04, 2021 (Market Insight Reports) -- The report on Onychomycosis provides the clients with a comprehensive analysis of crucial driving factors, consumer...
Market Insight Reports · 6d ago
Global Urticaria Drug Market Size & Share 2021, Development Analysis, Progression Status, Growth Segments, Competitive Panorama till 2027 Research Report by Industry Research Biz
Apr 29, 2021 (The Expresswire) -- Global “Urticaria Drug Market” Report analysis and insights 2021-2027 is a comprehensive analysis mainly on in-depth...
The Express Wire · 04/29 06:30
Cortisone Market Size to Reach USD 1.54 Billion by year 2026 | Reports And Data
Apr 27, 2021 (AB Digital via COMTEX) -- According to the current analysis of Reports and Data, the global Cortisone market was valued at USD 1.15...
ABNewswire · 04/28 00:35
Impetigo Treatment Market Share, Growth, Size, Global Industry Trends, Industry Analysis, Segments, COVID-19 Impact, Emerging Technologies, Opportunity and Forecast 2021 to 2027
Apr 27, 2021 (Market Insight Reports) -- Impetigo Treatment Market Size, Share, Growth Analysis especially in North America, Europe and Asia-Pacific, South...
Market Insight Reports · 04/27 06:06
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of TARO. Analyze the recent business situations of Taro Pharm through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average TARO stock price target is 81.00 with a high estimate of 81.00 and a low estimate of 81.00.
EPS
Institutional Holdings
Institutions: 142
Institutional Holdings: 5.50M
% Owned: 14.36%
Shares Outstanding: 38.26M
TypeInstitutionsShares
Increased
26
456.19K
New
16
115.34K
Decreased
23
257.39K
Sold Out
11
133.97K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
+0.20%
Pharmaceuticals & Medical Research
-0.44%
Key Executives
Chairman/Director
Dilip Shanghvi
Chief Executive Officer/Director
Uday Baldota
Vice Chairman/Director
Abhay Gandhi
Chief Financial Officer/Chief Accounting Officer/Vice President
Daphne Huang
Vice President/General Counsel/Secretary
Erik Zwicker
Vice President/Director of Human Resources
Michele Visosky
Vice President
Richard Glaze
Vice President
Ori Gutwerg
Vice President
Itamar Karsenti
Vice President
Chantal LeBlanc
Vice President - Research & Development
Avi Avramoff
Other
Jayesh Shah
Director
James Kedrowski
Director
Sudhir Valia
Independent Director
Linda Benshoshan
Independent Director
Dov Pekelman
Independent Director
Robert Stein
Declaration Date
Dividend Per Share
Ex-Div Date
11/05/2018
Dividend USD 0
12/10/2018
11/05/2018
Special Dividend USD 12.81
12/10/2018
About TARO
Taro Pharmaceutical Industries Ltd. (Taro) is a science-based pharmaceutical company. The Company operates principally through three entities: Taro Pharmaceutical Industries Ltd. (Taro Israel), and two of its subsidiaries, Taro Pharmaceuticals Inc. (Taro Canada) and Taro U.S.A. The Company markets over 200 pharmaceutical products in over 25 countries. The Company's owned product brands include Rokacet, with generic names, such as acetaminophen, codeine and caffeine; Topicort, with the generic name, desoximetasone; Etopan, with the generic name etodolac, and Ovide, with the generic name, malathion, among others. The Company's other generic products include acetazolamide, adapalene, alclometasone dipropionate, amiodarone hydrochloride, ammonium lactate, augmented betamethasone dipropionate, cetirizine hydrochloride, clobetasol propionate, clomipramine hydrochloride, clorazepate dipotassium, fluorouracil, ketoconazole, metronidazole, mupirocin and warfarin sodium, among others.

Webull offers kinds of Taro Pharmaceutical Industries Ltd. stock information, including NYSE:TARO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TARO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading TARO stock methods without spending real money on the virtual paper trading platform.